Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.

Identifieur interne : 000816 ( Ncbi/Curation ); précédent : 000815; suivant : 000817

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.

Auteurs : Chih-Jung Kuo [République populaire de Chine] ; Ya-Hui Chi ; John T-A Hsu ; Po-Huang Liang

Source :

RBID : pubmed:15147951

Descripteurs français

English descriptors

Abstract

SARS main protease is essential for life cycle of SARS coronavirus and may be a key target for developing anti-SARS drugs. Recently, the enzyme expressed in Escherichia coli was characterized using a HPLC assay to monitor the formation of products from 11 peptide substrates covering the cleavage sites found in the SARS viral genome. This protease easily dissociated into inactive monomer and the deduced Kd of the dimer was 100 microM. In order to detect enzyme activity, the assay needed to be performed at micromolar enzyme concentration. This makes finding the tight inhibitor (nanomolar range IC50) impossible. In this study, we prepared a peptide with fluorescence quenching pair (Dabcyl and Edans) at both ends of a peptide substrate and used this fluorogenic peptide substrate to characterize SARS main protease and screen inhibitors. The fluorogenic peptide gave extremely sensitive signal upon cleavage catalyzed by the protease. Using this substrate, the protease exhibits a significantly higher activity (kcat = 1.9 s(-1) and Km = 17 microM) compared to the previously reported parameters. Under our assay condition, the enzyme stays as an active dimer without dissociating into monomer and reveals a small Kd value (15 nM). This enzyme in conjunction with fluorogenic peptide substrate provides us a suitable tool for identifying potent inhibitors of SARS protease.

DOI: 10.1016/j.bbrc.2004.04.098
PubMed: 15147951

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:15147951

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.</title>
<author>
<name sortKey="Kuo, Chih Jung" sort="Kuo, Chih Jung" uniqKey="Kuo C" first="Chih-Jung" last="Kuo">Chih-Jung Kuo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan, ROC.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country>
<wicri:regionArea>Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chi, Ya Hui" sort="Chi, Ya Hui" uniqKey="Chi Y" first="Ya-Hui" last="Chi">Ya-Hui Chi</name>
</author>
<author>
<name sortKey="Hsu, John T A" sort="Hsu, John T A" uniqKey="Hsu J" first="John T-A" last="Hsu">John T-A Hsu</name>
</author>
<author>
<name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15147951</idno>
<idno type="pmid">15147951</idno>
<idno type="doi">10.1016/j.bbrc.2004.04.098</idno>
<idno type="wicri:Area/PubMed/Corpus">002D93</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D93</idno>
<idno type="wicri:Area/PubMed/Curation">002D93</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D93</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E00</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E00</idno>
<idno type="wicri:Area/Ncbi/Merge">000816</idno>
<idno type="wicri:Area/Ncbi/Curation">000816</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.</title>
<author>
<name sortKey="Kuo, Chih Jung" sort="Kuo, Chih Jung" uniqKey="Kuo C" first="Chih-Jung" last="Kuo">Chih-Jung Kuo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan, ROC.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country>
<wicri:regionArea>Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chi, Ya Hui" sort="Chi, Ya Hui" uniqKey="Chi Y" first="Ya-Hui" last="Chi">Ya-Hui Chi</name>
</author>
<author>
<name sortKey="Hsu, John T A" sort="Hsu, John T A" uniqKey="Hsu J" first="John T-A" last="Hsu">John T-A Hsu</name>
</author>
<author>
<name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
</author>
</analytic>
<series>
<title level="j">Biochemical and biophysical research communications</title>
<idno type="ISSN">0006-291X</idno>
<imprint>
<date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Dimerization</term>
<term>Endopeptidases (chemistry)</term>
<term>Endopeptidases (genetics)</term>
<term>Endopeptidases (metabolism)</term>
<term>Escherichia coli (genetics)</term>
<term>Escherichia coli (metabolism)</term>
<term>Fluorescence Resonance Energy Transfer</term>
<term>Fluorescent Dyes (metabolism)</term>
<term>Kinetics</term>
<term>Naphthalenesulfonates (metabolism)</term>
<term>Oligopeptides (metabolism)</term>
<term>Protease Inhibitors (pharmacology)</term>
<term>Recombinant Proteins (antagonists & inhibitors)</term>
<term>Recombinant Proteins (chemistry)</term>
<term>Recombinant Proteins (genetics)</term>
<term>Recombinant Proteins (metabolism)</term>
<term>SARS Virus (enzymology)</term>
<term>Substrate Specificity</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
<term>Viral Proteins (chemistry)</term>
<term>Viral Proteins (genetics)</term>
<term>Viral Proteins (metabolism)</term>
<term>p-Dimethylaminoazobenzene (analogs & derivatives)</term>
<term>p-Dimethylaminoazobenzene (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cinétique</term>
<term>Colorants fluorescents (métabolisme)</term>
<term>Dimérisation</term>
<term>Endopeptidases ()</term>
<term>Endopeptidases (génétique)</term>
<term>Endopeptidases (métabolisme)</term>
<term>Escherichia coli (génétique)</term>
<term>Escherichia coli (métabolisme)</term>
<term>Inhibiteurs de protéases (pharmacologie)</term>
<term>N,N-Diméthyl-4-phényldiazényl-aniline (analogues et dérivés)</term>
<term>N,N-Diméthyl-4-phényldiazényl-aniline (métabolisme)</term>
<term>Naphtalènesulfonates (métabolisme)</term>
<term>Oligopeptides (métabolisme)</term>
<term>Protéines recombinantes ()</term>
<term>Protéines recombinantes (antagonistes et inhibiteurs)</term>
<term>Protéines recombinantes (génétique)</term>
<term>Protéines recombinantes (métabolisme)</term>
<term>Protéines virales ()</term>
<term>Protéines virales (antagonistes et inhibiteurs)</term>
<term>Protéines virales (génétique)</term>
<term>Protéines virales (métabolisme)</term>
<term>Spécificité du substrat</term>
<term>Séquence d'acides aminés</term>
<term>Transfert d'énergie par résonance de fluorescence</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>p-Dimethylaminoazobenzene</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Recombinant Proteins</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Endopeptidases</term>
<term>Recombinant Proteins</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Endopeptidases</term>
<term>Recombinant Proteins</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Endopeptidases</term>
<term>Fluorescent Dyes</term>
<term>Naphthalenesulfonates</term>
<term>Oligopeptides</term>
<term>Recombinant Proteins</term>
<term>Viral Proteins</term>
<term>p-Dimethylaminoazobenzene</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>N,N-Diméthyl-4-phényldiazényl-aniline</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protéines recombinantes</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Escherichia coli</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Endopeptidases</term>
<term>Escherichia coli</term>
<term>Protéines recombinantes</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Escherichia coli</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Colorants fluorescents</term>
<term>Endopeptidases</term>
<term>Escherichia coli</term>
<term>N,N-Diméthyl-4-phényldiazényl-aniline</term>
<term>Naphtalènesulfonates</term>
<term>Oligopeptides</term>
<term>Protéines recombinantes</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de protéases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Dimerization</term>
<term>Fluorescence Resonance Energy Transfer</term>
<term>Kinetics</term>
<term>Substrate Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cinétique</term>
<term>Dimérisation</term>
<term>Endopeptidases</term>
<term>Protéines recombinantes</term>
<term>Protéines virales</term>
<term>Spécificité du substrat</term>
<term>Séquence d'acides aminés</term>
<term>Transfert d'énergie par résonance de fluorescence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">SARS main protease is essential for life cycle of SARS coronavirus and may be a key target for developing anti-SARS drugs. Recently, the enzyme expressed in Escherichia coli was characterized using a HPLC assay to monitor the formation of products from 11 peptide substrates covering the cleavage sites found in the SARS viral genome. This protease easily dissociated into inactive monomer and the deduced Kd of the dimer was 100 microM. In order to detect enzyme activity, the assay needed to be performed at micromolar enzyme concentration. This makes finding the tight inhibitor (nanomolar range IC50) impossible. In this study, we prepared a peptide with fluorescence quenching pair (Dabcyl and Edans) at both ends of a peptide substrate and used this fluorogenic peptide substrate to characterize SARS main protease and screen inhibitors. The fluorogenic peptide gave extremely sensitive signal upon cleavage catalyzed by the protease. Using this substrate, the protease exhibits a significantly higher activity (kcat = 1.9 s(-1) and Km = 17 microM) compared to the previously reported parameters. Under our assay condition, the enzyme stays as an active dimer without dissociating into monomer and reveals a small Kd value (15 nM). This enzyme in conjunction with fluorogenic peptide substrate provides us a suitable tool for identifying potent inhibitors of SARS protease.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000816 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000816 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:15147951
   |texte=   Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:15147951" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021